· Published by Health Canada · Official notice
Notice about Health Canada advisories
May 13, 2014
To: Hospital Chief of Medical Staff
Please distribute to the relevant Departments of Surgery, Gynecology, Urology, Emergency Medicine, Internal Medicine, Intensive Care and other involved professional staff and post this NOTICE in your institution.
Subject: Update - Complications Associated with Transvaginal Implantation of Surgical Mesh for the Treatment of Pelvic Organ Prolapse and Stress Urinary Incontinence
On February 4, 2010, Health Canada issued a Notice to Hospitals (NtH) informing healthcare professionals about complications associated with transvaginal implantation of surgical mesh for the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).Footnote 1 This update is being issued to inform you that although many women treated with these devices have had good outcomes, Health Canada continues to receive reports of complications, including some serious and life-altering events, associated with the use of these surgical devices.
The use of mesh devices for the surgical management of POP and SUI may share some overlapping risks and complications however, their associated incidence, severity, and the management of complications are different. It is important to recognize that some of these complications are not unique to mesh surgery and are known to occur with non-mesh procedures.
The traditional mid-urethral sling procedures for the treatment of SUI have been extensively studied, and are commonly performed for SUI repair.
The use of transvaginal surgical mesh devices has been associated with reports of acute or chronic pain, mesh erosion (extrusion or exposure), infection, voiding dysfunction, dyspareunia (pain during sexual intercourse), organ or blood vessel perforation, neuromuscular damage, bleeding or hemorrhage, as well as recurrent POP or SUI. Mesh contraction is an additional complication and its occurrence has been associated with reports of vaginal tightness and/or shortening. The presence and severity of the complications may vary from patient to patient. Revision surgery may be required and may not fully correct some complications.
Health Canada recommends that healthcare professionals provide information to perspective mesh candidates regarding these procedures and devices:
The nature of risk factors associated with the complications continues to be clinically investigated. Healthcare professionals are encouraged to update their knowledge by reviewing relevant scientific literature and clinical guidelines,Footnote 2,Footnote 3,Footnote 4 and attending relevant training courses related to the use of these devices.
Health Canada continues to monitor the complications associated with the use of transvaginal surgical mesh devices and to work with manufacturers to evaluate device safety and effectiveness data as they become available.
Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-marketing adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any cases of serious or unexpected adverse incidents in patients implanted with transvaginal surgical mesh devices for POP and SUI repair should be reported to Health Canada at the following address:
Any suspected adverse incident can be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline: 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc.public@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14626a-eng.php
http://sogc.org/wp-content/uploads/2013/01/gui254TU1102E.pdf
http://sogc.org/wp-content/uploads/2013/01/gui213TU0808.pdf
http://www.cua.org/userfiles/files/Incontinence Guidelines 1-2012(1).pdf